Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “inhibitor”

2,878 pharma patents match "inhibitor" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,878
Index total 30,257
Page 106 / 120

Quick answer

This filtered view shows 2,878 pharmaceutical patents matching "inhibitor" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,878 results for “inhibitor” · 30,257 patents in full index Clear search

  1. US 7288624

    Inhibitors of interleukin-1β converting enzyme

    Vertex Pharmaceuticals Incorporated · Granted Oct 30, 2007 · Expires Oct 25, 2027

    granted
  2. US 7285556

    Thienopyrimidine-based inhibitors of the src family

    The Board of Regents of the University of Texas System · Granted Oct 23, 2007 · Expires Oct 18, 2027

    granted
  3. US 7279476

    Pyrazole-derived kinase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Oct 9, 2007 · Expires Oct 4, 2027

    granted
  4. US 7279159

    VEGF inhibitor polypeptides

    REGENERON PHARMACEUTICALS, INC. · Granted Oct 9, 2007 · Expires Oct 4, 2027

    granted
  5. US 7279469

    Diaminotriazoles useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Oct 9, 2007 · Expires Oct 4, 2027

    granted
  6. US 7276502

    Thiazoles useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Oct 2, 2007 · Expires Sep 27, 2027

    granted
  7. US 7276348

    Compositions and methods relating to F1F0-ATPase inhibitors and targets thereof

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Oct 2, 2007 · Expires Sep 27, 2027

    granted
  8. US 7273885

    Inhibitors of serine proteases, particularly HCV NS3-NS4A protease

    Vertex Pharmaceuticals Incorporated · Granted Sep 25, 2007 · Expires Sep 20, 2027

    granted
  9. US 7273851

    Tri-peptide hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Sep 25, 2007 · Expires Sep 20, 2027

    granted
  10. US 7271186

    Nanomolar β-lactamase inhibitors

    Northwestern University · Granted Sep 18, 2007 · Expires Sep 13, 2027

    granted
  11. US 7271179

    Inhibitors of JAK protein kinase

    Vertex Pharmaceuticals Incorporated · Granted Sep 18, 2007 · Expires Sep 13, 2027

    granted
  12. US 7271181

    Inhibitors of p38

    Vertex Pharmaceuticals Incorporated · Granted Sep 18, 2007 · Expires Sep 13, 2027

    granted
  13. US 7268122

    Use of oversulfated polysaccharides as inhibitors of HIV

    FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR · Granted Sep 11, 2007 · Expires Sep 6, 2027

    granted
  14. US 7268136

    Compositions useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Sep 11, 2007 · Expires Sep 6, 2027

    granted
  15. US 7259161

    Compositions useful as inhibitors of JAK and other protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Aug 21, 2007 · Expires Aug 16, 2027

    granted
  16. US 7259142

    Redox-stable, non-phosphorylated cyclic peptide inhibitors of SH2 domain binding to target protein, conjugates thereof, compositions and methods of synthesis and use

    THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services · Granted Aug 21, 2007 · Expires Aug 16, 2027

    granted
  17. US 7256171

    Use of core 2 G1cNAc transferase inhibitors in treating inflammation

    The Regents of the University of California · Granted Aug 14, 2007 · Expires Aug 9, 2027

    granted
  18. US 7256190

    Thiazole compounds useful as inhibitors of protein kinase

    Vertex Pharmaceuticals Incorporated · Granted Aug 14, 2007 · Expires Aug 9, 2027

    granted
  19. US 7253187

    Heterocyclic inhibitors of ERK2 and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Aug 7, 2007 · Expires Aug 2, 2027

    granted
  20. US 7244735

    Heterocyclic protein kinase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Jul 17, 2007 · Expires Jul 12, 2027

    granted
  21. US 7241796

    Inhibitors of serine proteases, particularly HCV NS3-NS4A protease

    Vertex Pharmaceuticals Incorporated · Granted Jul 10, 2007 · Expires Jul 5, 2027

    granted
  22. US 7235529

    Brain-associated inhibitor of tissue-type plasminogen activator

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jun 26, 2007 · Expires Jun 21, 2027

    granted
  23. US 7235573

    Methods of treating secretory diarrhea using cystic fibrosis transmembrane conductance regulator protein inhibitors

    The Regents of the University of California · Granted Jun 26, 2007 · Expires Jun 21, 2027

    granted
  24. US 7229963

    Methods of using deacetylase inhibitors to promote cell differentiation and regeneration

    United States of America as represented by the Secretary of the Department of of Health Services, National Institutes of Health · Granted Jun 12, 2007 · Expires Jun 7, 2027

    granted